News 10.19.20

Berkeley Lights Announces Webcast of Third Quarter Financial Results on November 12, 2020

News 09.14.20

Biocytogen introduced its second Beacon® Optofluidic system from Berkeley Lights, and the two parties reached a strategic collaboration agreement

News 09.09.20

Berkeley Lights Makes Debut in Taiwan as Mycenax Acquires the BeaconⓇ Optofluidic System for Cell Line Development

News 09.01.20

Berkeley Lights to Participate in the Morgan Stanley 2020 Healthcare Conference

News 08.25.20

Berkeley Lights Reports Financial Results for Second Quarter of Fiscal Year 2020

News 07.21.20

Berkeley Lights Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

News 07.16.20

Berkeley Lights Announces Pricing of Initial Public Offering

News 07.02.20

Greg Lucier Joins Berkeley Lights’ Board of Directors

News 06.24.20

Berkeley Lights Announces Opto™ Antigen-Presenting Bead Kit to Accelerate the Expansion of Antigen-Specific T Cells Used to Develop Cell-Based Therapies

News 04.27.20

Berkeley Lights Launches Two New Capabilities in the Opto Cell Therapy Development 1.0 Workflow to Accelerate the Creation Of Effective Cancer Immunotherapies